2026 Global: Automated Breast Ultrasound Systems (Abus) Market -Competitive Review (2032) report
Description
The 2026 Global: Automated Breast Ultrasound Systems (Abus) Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for automated breast ultrasound systems (abus) market by geography and historical trend. The scope of the report extends to sizing of the automated breast ultrasound systems (abus) market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., Hologic, Hitachi Ltd., Canon Medical Systems, SonoCiné SAS, Fujifilm (including Fujifilm Holdings/Hitachi collaborations), Samsung Medison, and QT Ultrasound (including U-Systems/Delphinus-related product lines) are widely recognized as ten major companies active in the Automated Breast Ultrasound Systems (ABUS) market based on industry reports and market analyses.
GE HealthCare is a leading provider of ABUS products and integrated breast-imaging workflows, combining automated volumetric scanning platforms with AI-enabled image analysis and enterprise connectivity that support high-throughput screening programs and dense-breast adjunctive imaging strategies. Siemens Healthineers offers ABUS-capable solutions emphasizing ergonomic design, automation, and AI-assisted interpretation tools aimed at reducing operator dependency and improving reproducibility in population screening and diagnostic pathways. Koninklijke Philips N.V. competes with high-resolution ultrasound systems and software suites that integrate automated breast volume acquisition with advanced visualization and clinical decision support to assist radiologists in dense-breast assessment and lesion characterization. Hologic’s portfolio includes dedicated breast imaging systems and ABUS offerings focused on women’s health workflows; the company leverages clinical validation and service networks to position ABUS as a complementary screening tool to mammography and tomosynthesis. Hitachi Ltd. develops automated whole-breast ultrasound technologies and volumetric scanners with a history of R&D in breast imaging that target improved image quality and patient comfort for screening and diagnostic use.
Canon Medical Systems supplies ABUS-compatible ultrasound platforms that emphasize beamforming, elastography, and integration with advanced post‑processing to support both screening and diagnostic use cases in hospitals and imaging centers. SonoCiné SAS is a specialized ABUS developer known for dedicated automated breast volume scanning systems that focus on reproducible, operator‑independent acquisition and workflow efficiency for population screening and supplemental imaging of dense breasts. Fujifilm, through its medical imaging and ultrasound businesses, competes in the ABUS/ABVS space with systems emphasizing image fidelity and interoperability with PACS and reporting tools, often highlighted in market leader comparisons. Samsung Medison (Samsung) brings ultrasound hardware and software innovations to breast imaging, including automated volume acquisition and AI-assisted tools derived from its broader ultrasound platform investments and partnerships targeting OB/GYN and breast screening markets. QT Ultrasound and related focused innovators (including U-Systems/Delphinus and smaller specialized firms) supply niche ABUS/ABVS technologies and proprietary transducer designs aimed at cost-effective, high-resolution volumetric breast scanning for adjunct screening and diagnostic workflows.
Collectively these ten companies represent a mix of diversified medical-imaging conglomerates and focused specialists whose strategies combine hardware innovation (volumetric probes, elastography), software advances (AI, automated lesion detection), and clinical partnerships to expand ABUS adoption—particularly for women with dense breasts and in screening programs seeking improved sensitivity and workflow standardization.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for automated breast ultrasound systems (abus) market by geography and historical trend. The scope of the report extends to sizing of the automated breast ultrasound systems (abus) market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., Hologic, Hitachi Ltd., Canon Medical Systems, SonoCiné SAS, Fujifilm (including Fujifilm Holdings/Hitachi collaborations), Samsung Medison, and QT Ultrasound (including U-Systems/Delphinus-related product lines) are widely recognized as ten major companies active in the Automated Breast Ultrasound Systems (ABUS) market based on industry reports and market analyses.
GE HealthCare is a leading provider of ABUS products and integrated breast-imaging workflows, combining automated volumetric scanning platforms with AI-enabled image analysis and enterprise connectivity that support high-throughput screening programs and dense-breast adjunctive imaging strategies. Siemens Healthineers offers ABUS-capable solutions emphasizing ergonomic design, automation, and AI-assisted interpretation tools aimed at reducing operator dependency and improving reproducibility in population screening and diagnostic pathways. Koninklijke Philips N.V. competes with high-resolution ultrasound systems and software suites that integrate automated breast volume acquisition with advanced visualization and clinical decision support to assist radiologists in dense-breast assessment and lesion characterization. Hologic’s portfolio includes dedicated breast imaging systems and ABUS offerings focused on women’s health workflows; the company leverages clinical validation and service networks to position ABUS as a complementary screening tool to mammography and tomosynthesis. Hitachi Ltd. develops automated whole-breast ultrasound technologies and volumetric scanners with a history of R&D in breast imaging that target improved image quality and patient comfort for screening and diagnostic use.
Canon Medical Systems supplies ABUS-compatible ultrasound platforms that emphasize beamforming, elastography, and integration with advanced post‑processing to support both screening and diagnostic use cases in hospitals and imaging centers. SonoCiné SAS is a specialized ABUS developer known for dedicated automated breast volume scanning systems that focus on reproducible, operator‑independent acquisition and workflow efficiency for population screening and supplemental imaging of dense breasts. Fujifilm, through its medical imaging and ultrasound businesses, competes in the ABUS/ABVS space with systems emphasizing image fidelity and interoperability with PACS and reporting tools, often highlighted in market leader comparisons. Samsung Medison (Samsung) brings ultrasound hardware and software innovations to breast imaging, including automated volume acquisition and AI-assisted tools derived from its broader ultrasound platform investments and partnerships targeting OB/GYN and breast screening markets. QT Ultrasound and related focused innovators (including U-Systems/Delphinus and smaller specialized firms) supply niche ABUS/ABVS technologies and proprietary transducer designs aimed at cost-effective, high-resolution volumetric breast scanning for adjunct screening and diagnostic workflows.
Collectively these ten companies represent a mix of diversified medical-imaging conglomerates and focused specialists whose strategies combine hardware innovation (volumetric probes, elastography), software advances (AI, automated lesion detection), and clinical partnerships to expand ABUS adoption—particularly for women with dense breasts and in screening programs seeking improved sensitivity and workflow standardization.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.